This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Ucb Pharma Gmbh. Active years: 2014-2015.
Company Filing History:
Years Active: 2014-2015
Title: David Vasselin: Innovator in Pharmaceutical Chemistry
Introduction
David Vasselin is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and processes. With a total of three patents to his name, Vasselin's work has the potential to impact the medical industry positively.
Latest Patents
Vasselin's latest patents include a process for the preparation of nitrogen substituted aminotetralins derivatives. This invention provides an alternative synthesis of N-substituted aminotetralines, which are important in various chemical applications. Another significant patent is related to the preparation of amino acid derivatives. This process involves the hydrogenation of compounds, leading to the manufacture of Lacosamide, a compound useful as an anticonvulsive drug.
Career Highlights
David Vasselin is currently employed at UCB Pharma GmbH, a leading global biopharmaceutical company. His work at UCB Pharma focuses on innovative drug development, contributing to the advancement of therapeutic solutions for patients.
Collaborations
Vasselin collaborates with several talented individuals in his field, including coworkers Nicolas Edmond Carly and Celal Ates. These collaborations enhance the research and development efforts within his team.
Conclusion
David Vasselin's contributions to pharmaceutical chemistry through his patents and work at UCB Pharma highlight his role as an influential inventor. His innovative approaches to drug development continue to pave the way for advancements in medical treatments.